CAS 22994-85-0|Benznidazole

Introduction：Basic information about CAS 22994-85-0|Benznidazole, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Benznidazole BiologicalActivity
3. Chemical & Physical Properties
4. Toxicological Information
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
MUTATION DATA
5. Safety Information
6. Customs
7. Articles37
8. Synonyms

Common Name	Benznidazole
CAS Number	22994-85-0	Molecular Weight	260.24900
Density	1.35g/cm3	Boiling Point	/
Molecular Formula	C₁₂H₁₂N₄O₃	Melting Point	189-192ºC(lit.)
MSDS	ChineseUSA	Flash Point	/
Symbol	GHS07	Signal Word	Warning

Names

Name	Benznidazole
Synonym	More Synonyms

Benznidazole BiologicalActivity

Description	Benznidazol (Ro 07-1051) is an antiparasitic medication, with an IC50 of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease[1][2].
Related Catalog	Signaling Pathways >>Anti-infection >>ParasiteResearch Areas >>Infection
In Vivo	Benznidazole (100 mg/kg/day, p.o., 30 days) produces a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart, in mice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12 isolate and treated at 180 days post infection (p.i.) (i.e. chronic phase) with Benznidazole[1]. Animal Model: Mice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12[1] Dosage: 100 mg/kg/day Administration: Orally for 30 days Result: Produced a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart.
References	[1]. Bustamante JM, et al. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy. Int J Antimicrob Agents. 2007 Jun;29(6):733-7. [2]. Luna KP, et al. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole. Biomedica. 2009 Sep;29(3):448-55.

Chemical & Physical Properties

Density	1.35g/cm3
Melting Point	189-192ºC(lit.)
Molecular Formula	C₁₂H₁₂N₄O₃
Molecular Weight	260.24900
Exact Mass	260.09100
PSA	92.74000
LogP	2.02180
Index of Refraction	1.643
InChIKey	CULUWZNBISUWAS-UHFFFAOYSA-N
SMILES	O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1
Storage condition	-20℃

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: NI3340000

CHEMICAL NAME :: Imidazole-1-acetamide, N-benzyl-2-nitro-

CAS REGISTRY NUMBER :: 22994-85-0

BEILSTEIN REFERENCE NO. :: 0551486

LAST UPDATED :: 199612

DATA ITEMS CITED :: 9

MOLECULAR FORMULA :: C12-H12-N4-O3

MOLECULAR WEIGHT :: 260.28

WISWESSER LINE NOTATION :: T5N CNJ A1VM1R& BNW

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 8 gm/kg

SEX/DURATION :: male 8 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :: Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :: Sister chromatid exchange

TEST SYSTEM :: Human Lymphocyte

DOSE/DURATION :: 50 mg/L

REFERENCE :: MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 320,305,1994

Safety Information

Symbol	GHS07
Signal Word	Warning
Hazard Statements	H315-H319-H335
Precautionary Statements	P261-P305 + P351 + P338
Personal Protective Equipment	dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes	Xi: Irritant;
Risk Phrases	R36/37/38
Safety Phrases	26-36
RIDADR	NONH for all modes of transport
RTECS	NI3340000
HS Code	2933290090

Customs

HS Code	2933290090
Summary	2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles37

Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.

Antimicrob. Agents Chemother. 56(11) , 5821-30, (2012)

Nitroheterocyclic prodrugs are used to treat infections caused by Trypanosoma cruzi and Trypanosoma brucei. A key component in selectivity involves a specific activation step mediated by a protein hom...

Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole.

Vector Borne Zoonotic Dis. 13(3) , 181-7, (2013)

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and it affects as many as 10 million people in North and South America, where it represents a major public health problem. T. cruz...

Immunosuppression and Chagas disease: a management challenge.

PLoS Negl. Trop. Dis. 7(1) , e1965, (2013)

Immunosuppression, which has become an increasingly relevant clinical condition in the last 50 years, modifies the natural history of Trypanosoma cruzi infection in most patients with Chagas disease. ...

Synonyms

MFCD00243089

N-benzyl-2-(2-nitroimidazol-1-yl)acetamide

1H-Imidazole-1-acetamide,2-nitro-N-(phenylmethyl)-

Recommended......